
    
      -  Prospective, observational international cohort study.

        -  Any hospital worldwide can participate (including hospitals that have not admitted
           SARS-CoV-2 infected patients).

        -  All patients undergoing a surgical procedure in an operating theatre will be included.
           All consecutive eligible patients should be included.

        -  7-day data collection period, with follow-up at 30 days after surgery for each patient.
           However, no changes should be made to normal patient care/ follow-up pathways

        -  Primary outcome is 30-day mortality.

        -  All collaborators will be included as PubMed-citable co-authors on resulting
           publications.
    
  